Related Experiment Videos
Can interstitial glucose assessment replace blood glucose measurements?
Diabetes Technology & Therapeutics
|July 27, 2001
Summary
Continuous glucose monitoring aims to replace finger sticks. This study confirms interstitial fluid (ISF) glucose closely mirrors blood glucose, with minimal error (<6%), supporting its use in diabetes management.
Area of Science:
- Biomedical Engineering
- Endocrinology
- Physiology
Background:
- Current diabetes management relies on invasive blood glucose measurements.
- Continuous glucose monitoring (CGM) shifts to interstitial fluid (ISF) glucose.
- Understanding the plasma-ISF glucose dynamic relationship is crucial for CGM accuracy.
Purpose of the Study:
- To investigate the dynamic relationship between plasma and interstitial fluid (ISF) glucose.
- To establish the time delay and error associated with using ISF glucose as a surrogate for blood glucose.
- To validate a two-compartment model for glucose dynamics.
Main Methods:
- Utilized a validated two-compartment model.
- Analyzed glucose dynamics in plasma and hindlimb lymph (ISF surrogate) in anesthetized dogs.
- Performed simulation studies to quantify errors.
Main Results:
- Established a plasma-to-ISF glucose time delay of 5-12 minutes in dogs.
- Simulation indicated an error component of <6% when using ISF as a blood surrogate.
- This error is comparable to intra-body blood glucose variations.
Conclusions:
- The dynamic differences between plasma and ISF glucose are minimal.
- ISF glucose measurements are a viable alternative to blood glucose monitoring for diabetes management.
- This supports the advancement of noninvasive continuous glucose monitoring technologies.